FDA Import Refusal 1FX-7441795-7/10002/1D — Across Co., Ltd
The FDA refused shipment 1FX-7441795-7/10002/1D from Across Co., Ltd (South Korea) on Aug 14, 2026. The refused product falls under Devices — ACID, HYALURONIC, INTRAARTICULAR. Cited charge: 9999976 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 14, 2026
- Country
- South Korea
- Product Category
- Devices
- Product Code
- 87MOZ ACID, HYALURONIC, INTRAARTICULAR
- Charges
- 9999976